These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20826546)

  • 1. Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells.
    Galbaugh T; Feeney YB; Clevenger CV
    Mol Cancer Res; 2010 Oct; 8(10):1413-24. PubMed ID: 20826546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R; Tsai Morris CH; Dufau ML
    Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
    Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
    Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of prolactin receptor in GH signaling in breast cancer cells.
    Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
    Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
    Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
    Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.
    Carver KC; Piazza TM; Schuler LA
    J Biol Chem; 2010 Mar; 285(11):8003-12. PubMed ID: 20080972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2017 Apr; 8(16):27353-27363. PubMed ID: 28423697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
    Kavarthapu R; Dufau ML
    Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
    Chughtai N; Schimchowitsch S; Lebrun JJ; Ali S
    J Biol Chem; 2002 Aug; 277(34):31107-14. PubMed ID: 12060651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
    Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
    Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
    Sakamoto K; Triplett AA; Schuler LA; Wagner KU
    Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.
    Fiorillo AA; Medler TR; Feeney YB; Wetz SM; Tommerdahl KL; Clevenger CV
    Am J Pathol; 2013 Jan; 182(1):217-33. PubMed ID: 23159947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: inhibition by glucocorticoids.
    Olazabal I; Muñoz J; Ogueta S; Obregón E; García-Ruiz JP
    Mol Endocrinol; 2000 Apr; 14(4):564-75. PubMed ID: 10770493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferation.
    Varghese B; Swaminathan G; Plotnikov A; Tzimas C; Yang N; Rui H; Fuchs SY
    Mol Endocrinol; 2010 Dec; 24(12):2356-65. PubMed ID: 20962042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
    Ali S; Ali S
    J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.